Statin therapy and levels of hemostatic factors in a healthy population: The Multi-Ethnic study of atherosclerosis

N. B. Adams, P. L. Lutsey, A. R. Folsom, D. H. Herrington, C. T. Sibley, N. A. Zakai, S. Ades, G. L. Burke, M. Cushman

Research output: Contribution to journalArticle

Abstract

Background: HMG-CoA reductase inhibitors (statins) reduce the risk of venous thromboembolism (VTE) in healthy people. Statins reduce levels of inflammation biomarkers; however, the mechanism for the reduction in VTE risk is unknown. Aim: In a large cohort of healthy people, we studied associations of statin use with plasma hemostatic factors related to VTE risk. Methods: Cross-sectional analyses were performed in the Multi-Ethnic Study of Atherosclerosis (MESA), a cohort study of 6814 healthy men and women aged 45-84 years, free of clinical cardiovascular disease at baseline; 1001 were using statins at baseline. Twenty-three warfarin users were excluded. Age, race and sex-adjusted mean hemostatic factor levels were compared between statin users and non-users, and multivariable linear regression models were used to assess associations of statin use with hemostatic factors, adjusted for age, race/ethnicity, education, income, aspirin use, hormone replacement therapy (in women), and major cardiovascular risk factors. Results: Participants using statins had lower adjusted levels of D-dimer (- 9%), C-reactive protein (- 21%) and factor VIII (- 3%) than non-users (P 

Original languageEnglish (US)
Pages (from-to)1078-1084
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Volume11
Issue number6
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hemostatics
Atherosclerosis
Population
Venous Thromboembolism
Therapeutics
Linear Models
Age Factors
Hormone Replacement Therapy
Warfarin
C-Reactive Protein
Aspirin
Cohort Studies
Cardiovascular Diseases
Cross-Sectional Studies
Biomarkers
Inflammation
Education

Keywords

  • Blood coagulation
  • Fibrinolysis
  • Inflammation
  • Risk factor
  • Statins
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Adams, N. B., Lutsey, P. L., Folsom, A. R., Herrington, D. H., Sibley, C. T., Zakai, N. A., ... Cushman, M. (2013). Statin therapy and levels of hemostatic factors in a healthy population: The Multi-Ethnic study of atherosclerosis. Journal of Thrombosis and Haemostasis, 11(6), 1078-1084. https://doi.org/10.1111/jth.12223

Statin therapy and levels of hemostatic factors in a healthy population : The Multi-Ethnic study of atherosclerosis. / Adams, N. B.; Lutsey, P. L.; Folsom, A. R.; Herrington, D. H.; Sibley, C. T.; Zakai, N. A.; Ades, S.; Burke, G. L.; Cushman, M.

In: Journal of Thrombosis and Haemostasis, Vol. 11, No. 6, 06.2013, p. 1078-1084.

Research output: Contribution to journalArticle

Adams, NB, Lutsey, PL, Folsom, AR, Herrington, DH, Sibley, CT, Zakai, NA, Ades, S, Burke, GL & Cushman, M 2013, 'Statin therapy and levels of hemostatic factors in a healthy population: The Multi-Ethnic study of atherosclerosis', Journal of Thrombosis and Haemostasis, vol. 11, no. 6, pp. 1078-1084. https://doi.org/10.1111/jth.12223
Adams, N. B. ; Lutsey, P. L. ; Folsom, A. R. ; Herrington, D. H. ; Sibley, C. T. ; Zakai, N. A. ; Ades, S. ; Burke, G. L. ; Cushman, M. / Statin therapy and levels of hemostatic factors in a healthy population : The Multi-Ethnic study of atherosclerosis. In: Journal of Thrombosis and Haemostasis. 2013 ; Vol. 11, No. 6. pp. 1078-1084.
@article{3b2a36fd6d944eb9a50038c85b498b0d,
title = "Statin therapy and levels of hemostatic factors in a healthy population: The Multi-Ethnic study of atherosclerosis",
abstract = "Background: HMG-CoA reductase inhibitors (statins) reduce the risk of venous thromboembolism (VTE) in healthy people. Statins reduce levels of inflammation biomarkers; however, the mechanism for the reduction in VTE risk is unknown. Aim: In a large cohort of healthy people, we studied associations of statin use with plasma hemostatic factors related to VTE risk. Methods: Cross-sectional analyses were performed in the Multi-Ethnic Study of Atherosclerosis (MESA), a cohort study of 6814 healthy men and women aged 45-84 years, free of clinical cardiovascular disease at baseline; 1001 were using statins at baseline. Twenty-three warfarin users were excluded. Age, race and sex-adjusted mean hemostatic factor levels were compared between statin users and non-users, and multivariable linear regression models were used to assess associations of statin use with hemostatic factors, adjusted for age, race/ethnicity, education, income, aspirin use, hormone replacement therapy (in women), and major cardiovascular risk factors. Results: Participants using statins had lower adjusted levels of D-dimer (- 9{\%}), C-reactive protein (- 21{\%}) and factor VIII (- 3{\%}) than non-users (P ",
keywords = "Blood coagulation, Fibrinolysis, Inflammation, Risk factor, Statins, Thrombosis",
author = "Adams, {N. B.} and Lutsey, {P. L.} and Folsom, {A. R.} and Herrington, {D. H.} and Sibley, {C. T.} and Zakai, {N. A.} and S. Ades and Burke, {G. L.} and M. Cushman",
year = "2013",
month = "6",
doi = "10.1111/jth.12223",
language = "English (US)",
volume = "11",
pages = "1078--1084",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Statin therapy and levels of hemostatic factors in a healthy population

T2 - The Multi-Ethnic study of atherosclerosis

AU - Adams, N. B.

AU - Lutsey, P. L.

AU - Folsom, A. R.

AU - Herrington, D. H.

AU - Sibley, C. T.

AU - Zakai, N. A.

AU - Ades, S.

AU - Burke, G. L.

AU - Cushman, M.

PY - 2013/6

Y1 - 2013/6

N2 - Background: HMG-CoA reductase inhibitors (statins) reduce the risk of venous thromboembolism (VTE) in healthy people. Statins reduce levels of inflammation biomarkers; however, the mechanism for the reduction in VTE risk is unknown. Aim: In a large cohort of healthy people, we studied associations of statin use with plasma hemostatic factors related to VTE risk. Methods: Cross-sectional analyses were performed in the Multi-Ethnic Study of Atherosclerosis (MESA), a cohort study of 6814 healthy men and women aged 45-84 years, free of clinical cardiovascular disease at baseline; 1001 were using statins at baseline. Twenty-three warfarin users were excluded. Age, race and sex-adjusted mean hemostatic factor levels were compared between statin users and non-users, and multivariable linear regression models were used to assess associations of statin use with hemostatic factors, adjusted for age, race/ethnicity, education, income, aspirin use, hormone replacement therapy (in women), and major cardiovascular risk factors. Results: Participants using statins had lower adjusted levels of D-dimer (- 9%), C-reactive protein (- 21%) and factor VIII (- 3%) than non-users (P 

AB - Background: HMG-CoA reductase inhibitors (statins) reduce the risk of venous thromboembolism (VTE) in healthy people. Statins reduce levels of inflammation biomarkers; however, the mechanism for the reduction in VTE risk is unknown. Aim: In a large cohort of healthy people, we studied associations of statin use with plasma hemostatic factors related to VTE risk. Methods: Cross-sectional analyses were performed in the Multi-Ethnic Study of Atherosclerosis (MESA), a cohort study of 6814 healthy men and women aged 45-84 years, free of clinical cardiovascular disease at baseline; 1001 were using statins at baseline. Twenty-three warfarin users were excluded. Age, race and sex-adjusted mean hemostatic factor levels were compared between statin users and non-users, and multivariable linear regression models were used to assess associations of statin use with hemostatic factors, adjusted for age, race/ethnicity, education, income, aspirin use, hormone replacement therapy (in women), and major cardiovascular risk factors. Results: Participants using statins had lower adjusted levels of D-dimer (- 9%), C-reactive protein (- 21%) and factor VIII (- 3%) than non-users (P 

KW - Blood coagulation

KW - Fibrinolysis

KW - Inflammation

KW - Risk factor

KW - Statins

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84883759845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883759845&partnerID=8YFLogxK

U2 - 10.1111/jth.12223

DO - 10.1111/jth.12223

M3 - Article

C2 - 23565981

AN - SCOPUS:84883759845

VL - 11

SP - 1078

EP - 1084

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 6

ER -